PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.74%
Net income growth under 50% of ORCL's 75.15%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
9.16%
D&A growth well above ORCL's 1.80%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-12.72%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-1.99%
Negative yoy SBC while ORCL is 4.33%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
130.22%
Less working capital growth vs. ORCL's 412.87%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-698.58%
Both yoy AR lines negative, with ORCL at -991.07%. Martin Whitman would suspect an overall sector lean approach or softer demand.
252.83%
Inventory growth of 252.83% while ORCL is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
422.11%
Lower AP growth vs. ORCL's 25000.00%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
288.57%
Growth well above ORCL's 304.52%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
210.00%
Some yoy increase while ORCL is negative at -12.12%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
17.71%
Operating cash flow growth at 50-75% of ORCL's 32.09%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-35.36%
Negative yoy CapEx while ORCL is 27.21%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-13.29%
Negative yoy acquisition while ORCL stands at 2352.56%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-32.14%
Negative yoy purchasing while ORCL stands at 18.24%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-13.88%
We reduce yoy sales while ORCL is 523.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
84.05%
We have some outflow growth while ORCL is negative at -739.04%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-179.84%
We reduce yoy invests while ORCL stands at 41.97%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-4.48%
Negative yoy issuance while ORCL is 341.84%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-3.54%
Both yoy lines negative, with ORCL at -6.10%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.